New Alzheimer’s drug rejected for PBS listing, leaving patients to pay up to $80k a year admin 3 hours ago Latest News Comments Off on New Alzheimer’s drug rejected for PBS listing, leaving patients to pay up to $80k a year 3 Views A federal government advisory body has refused to recommend listing a new Alzheimer’s drug, leaving patients to bear staggering costs to use it. Share Facebook Twitter Stumbleupon LinkedIn Pinterest
